ArticleCell death & disease2020

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.

Qiongyu Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.